| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |